Brief: Neuren Pharmaceuticals Posts FY Profit After Tax A$0.2 Mln Vs Loss A$7.8 Mln
24/02/2023 01:20
Feb 24 (Reuters) - Neuren Pharmaceuticals Ltd NEU.AX :
* FY PROFIT AFTER TAX A$0.2 MILLION VERSUS LOSS AFTER TAX OF
A$7.8
MILLION
* FY REVENUE FROM ORDINARY ACTIVITIES A$14.6 MILLION
Source text for Eikon: ID:nASX15qCmM
Further company coverage: NEU.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Neuren Pharmaceuticals
See all newsAustralia's Neuren set for weekly gain on FDA nod, drug forecast upgrade
Australia's Neuren Pharmaceuticals gains on upbeat FY trofinetide earnings outlook
Australia's Neuren Pharma rises as US FDA grants orphan tag for NNZ-2591
Strong partner sales propel Neuren Pharmaceuticals to top of Australia benchmark
Brief: Neuren Pharmaceuticals Says DAYBU Recommended For Approval In European Union